A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)

Clinical trial NCT03013114 · UNKNOWN

Trial details

NCT number: NCT03013114
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2017-01-01
Primary completion: 2017-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.